CSIMarket
 


Akers Biosciences Inc   (AKER)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare

Cumulative Akers Biosciences Inc 's Quick Ratio for Trailing Twelve Months Period

AKER's Quick Ratio for Trailing Twelve Months Period and Cash & cash equivalent, Current Liabilities growth


Select the Comparisons : Select the Ratio:

AKER Quick Ratio for Trailing Twelve Months Period

(Sep 30 2020)
III. Quarter
(Jun 30 2020)
II. Quarter
(Mar 31 2020)
I. Quarter
(Dec 31 2019)
IV. Quarter
(Sep 30 2019)
III. Quarter
Y / Y Current Liabilities Growth 83.19 % 62.3 % 4.99 % -22.48 % -40.34 %
Y / Y Cash & cash equivalent Growth 620.55 % 328.76 % 56.57 % 77.49 % -47.98 %
Quick Ratio for Trailing Twelve Months Period 6.61 5.01 3.67 3.32 2.51
Total Ranking # 357 # 490 # 650 # 716 # 834
Seq. Current Liabilities Growth -4.21 % 20.44 % 42.5 % 11.42 % -15.13 %
Seq. Cash & cash equivalent Growth 26.31 % 145.95 % -23.13 % 201.75 % -24.84 %


Quick Ratio for Trailing Twelve Months Period Comment
On the trailing twelve months basis Akers Biosciences Inc Cash & cash equivalent average more than doubled by 620.55 % in III. Quarter year on year, faster than Current Liabilities, this led to increase in in Akers Biosciences Inc 's Quick Ratio for Trailing Twelve Months Period to 6.61, Quick Ratio for Trailing Twelve Months Period remained below Akers Biosciences Inc average.
Quick Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Biotechnology & Drugs industry 62 other companies have achieved higher Quick Ratio for Trailing Twelve Months Period than Akers Biosciences Inc . While Quick Ratio for Trailing Twelve Months Period overall ranking has improved so far to 357, from total ranking in previous quarter at 490.

What is Quick Ratio?
Learn more about AKER
Quick Ratio AKER in the most recent quarter
Quick Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 63
Sector # 191
S&P 500 # 350


Quick Ratio for Trailing Twelve Months Period Statistics
High Average Low
6.53 2.84 0.6
(Sep 30 2020)   (Sep 30 2017)




Companies with similar average Quick Ratio for Trailing Twelve Months Period for 12 months ending Sep 30 2020, within Biotechnology & Drugs Industry Quick Ratio for Trailing Twelve Months Period
Arca Biopharma Inc   16.25 
Assembly Biosciences inc   16.21 
Scpharmaceuticals Inc   15.73 
Acceleron Pharma inc  15.25 
Organovo Holdings Inc   14.81 
Capricor Therapeutics Inc   14.70 
Audentes Therapeutics Inc   14.37 
Adverum Biotechnologies Inc   14.26 
Satsuma Pharmaceuticals Inc   14.24 
89bio Inc   14.18 
Forma Therapeutics Holdings Inc   14.08 
Myokardia Inc   14.05 
Aerpio Pharmaceuticals Inc   13.97 
Aim Immunotech Inc   13.92 
Checkmate Pharmaceuticals Inc   13.74 
Eidos Therapeutics Inc   13.66 
Homology Medicines Inc  13.52 
Crispr Therapeutics Ag  13.14 
Iovance Biotherapeutics inc   13.12 
Oxford Immunotec Global Plc  13.01 
Repligen Corp  12.87 
Livongo Health Inc   12.34 
Madrigal Pharmaceuticals Inc   12.04 
Celldex Therapeutics Inc   11.68 
Protokinetix Inc   11.48 
Fennec Pharmaceuticals Inc   10.89 
G1 Therapeutics Inc   10.87 
Immunomedics Inc   10.73 
Jounce Therapeutics Inc   10.20 
Lixte Biotechnology Holdings Inc   10.17 


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

RBOI's Profile

Stock Price

RBOI's Financials

Business Description

Fundamentals

Charts & Quotes

RBOI's News

Suppliers

RBOI's Competitors

Customers & Markets

Economic Indicators

RBOI's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071